ACA
JNJ icon

Aptus Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Aptus Capital Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-21,600
Closed -$3.15M – 470
2019
Q4 		$3.15M Buy
21,600
+3,900
+22% +$529K 0.22% 85
2019
Q3 		$2.29M Buy
+17,700
New +$2.33M 0.13% 109

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Aptus Capital Advisors's JNJ Position: Q2 2026 in Review

Aptus Capital Advisors increased its Johnson & Johnson (JNJ) stake by 4.4% in Q2 2026, buying an estimated $1.99M and bringing the position to 201,691 shares worth $51.2M. The position accounts for 0.35% of the portfolio, ranked #63.

Aptus Capital Advisors first reported a position in JNJ in Q1 2019 and has held it in 30 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Aptus Capital Advisors held 201,691 shares of Johnson & Johnson worth $51.2M as of Q2 2026.
  • Aptus Capital Advisors bought 8,547 Johnson & Johnson shares in Q2 2026, an estimated $1.99M.
  • Johnson & Johnson made up 0.35% of Aptus Capital Advisors's portfolio in Q2 2026, its #63 holding.
  • Aptus Capital Advisors first reported a position in Johnson & Johnson in Q1 2019 and has held it in 30 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.